RXRX Competitors & Alternatives
Compare Recursion Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RXRX
Main Stock$3.59
Tradestie Score
50
Market Cap
$2.23B
Revenue Growth
2.6%
Analyst Upside
+103.8%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$28.38
|
$2.37B | 124.5 | 44 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$6.67
|
$2.34B | - | 42 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$87.08
|
$2.33B | - | 37 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$32.82
|
$2.33B | - | 44 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.94
|
$2.22B | - | 40 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$52.04
|
$2.21B | - | 66 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$19.73
|
$2.18B | - | 49 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$13.65
|
$2.08B | - | 44 | Compare |
More RXRX Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry